Guselkumab Deemed Effective for PsA Previously Treated With TNFi Guselkumab Deemed Effective for PsA Previously Treated With TNFi

COSMOS trial results in patients with psoriatic arthritis fit with the expectation that"people who ' ve previously failed a TNF inhibitor might be a little less likely to respond to guselkumab."Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Rheumatology News Source Type: news